- Home
- AKRO vs DXC Comparison
AKRO vs DXC Comparison
Compare AKRO & DXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- DXC
- Stock Information
- Founded
- AKRO 2017
- DXC 1959
- Country
- AKRO United States
- DXC United States
- Employees
- AKRO N/A
- DXC N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- DXC EDP Services
- Sector
- AKRO Health Care
- DXC Technology
- Exchange
- AKRO Nasdaq
- DXC Nasdaq
- Market Cap
- AKRO 2.8B
- DXC 2.5B
- IPO Year
- AKRO 2019
- DXC N/A
- Fundamental
- Price
- AKRO $39.85
- DXC $16.26
- Analyst Decision
- AKRO Strong Buy
- DXC Hold
- Analyst Count
- AKRO 9
- DXC 7
- Target Price
- AKRO $76.29
- DXC $20.29
- AVG Volume (30 Days)
- AKRO 1.1M
- DXC 1.1M
- Earning Date
- AKRO 05-16-2025
- DXC 05-14-2025
- Dividend Yield
- AKRO N/A
- DXC N/A
- EPS Growth
- AKRO N/A
- DXC N/A
- EPS
- AKRO N/A
- DXC N/A
- Revenue
- AKRO N/A
- DXC $13,088,000,000.00
- Revenue This Year
- AKRO N/A
- DXC N/A
- Revenue Next Year
- AKRO N/A
- DXC N/A
- P/E Ratio
- AKRO N/A
- DXC N/A
- Revenue Growth
- AKRO N/A
- DXC N/A
- 52 Week Low
- AKRO $17.86
- DXC $13.44
- 52 Week High
- AKRO $58.40
- DXC $24.83
- Technical
- Relative Strength Index (RSI)
- AKRO 44.56
- DXC 55.55
- Support Level
- AKRO $41.60
- DXC $15.19
- Resistance Level
- AKRO $46.47
- DXC $16.30
- Average True Range (ATR)
- AKRO 2.26
- DXC 0.45
- MACD
- AKRO 0.08
- DXC 0.20
- Stochastic Oscillator
- AKRO 21.84
- DXC 98.16
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About DXC DXC Technology Company
DXC Technology Co is a vendor-independent IT services provider. The company's operating segment includes Global Business Services (GBS) and Global Infrastructure Services (GIS). It generates maximum revenue from the GIS segment. GIS offerings include Cloud and Security; IT Outsourcing and Modern Workplace. Geographically, it derives a majority of revenue from the Other Europe region.